AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Inovio PharmaceuticalsSilk Road MedicalShockwave MedicalAtrionAtriCure
SymbolNASDAQ:INONASDAQ:SILKNASDAQ:SWAVNASDAQ:ATRINASDAQ:ATRC
Price Information
Current Price$14.34$38.95$44.55$647.30$44.94
52 Week RangeBuyBuyBuyN/ABuy
Beat the Market™ Rank
Overall Score1.21.51.31.31.4
Analysis Score2.43.52.30.02.4
Community Score3.12.42.42.32.9
Dividend Score0.00.00.03.30.0
Ownership Score0.01.01.01.01.0
Earnings & Valuation Score0.60.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$12.33$49.67$42.57N/A$46.22
% Upside from Price Target-13.99% downside27.51% upside-4.44% downsideN/A2.85% upside
Trade Information
Market Cap$2.33 billion$1.20 billion$1.40 billion$1.18 billion$1.88 billion
Beta1.391.620.820.160.8
Average Volume30,549,516422,607451,7857,320481,016
Sales & Book Value
Annual Revenue$4.11 million$63.35 million$42.93 million$155.07 million$230.81 million
Price / Sales551.6119.3533.067.677.80
CashflowN/AN/AN/A$25.88 per shareN/A
Price / CashN/AN/AN/A25.01N/A
Book Value$0.05 per share$2.33 per share$6.81 per share$128.24 per share$6.25 per share
Price / Book286.8016.726.545.057.19
Profitability
Net Income$-119,360,000.00$-52,420,000.00$-51,110,000.00$36.76 million$-35,190,000.00
EPS($1.16)($1.36)($2.14)N/A($1.07)
Trailing P/E RatioN/AN/AN/A33.28N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-4,700.42%-54.94%-112.25%23.06%-19.98%
Return on Equity (ROE)-166.85%-44.17%-38.18%15.57%-19.19%
Return on Assets (ROA)-59.66%-24.11%-30.97%14.09%-9.40%
Dividend
Annual PayoutN/AN/AN/A$6.20N/A
Dividend YieldN/AN/AN/A0.96%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/A17 YearsN/A
Debt
Debt-to-Equity Ratio0.51%0.70%0.14%N/A0.32%
Current Ratio8.53%8.40%10.53%9.88%3.25%
Quick Ratio8.53%7.56%9.68%6.70%2.43%
Ownership Information
Institutional Ownership Percentage27.82%98.34%78.93%65.79%89.93%
Insider Ownership Percentage4.00%7.80%15.30%22.44%5.80%
Miscellaneous
Employees281176162570620
Shares Outstanding158.10 million31.47 million31.86 million1.84 million40.07 million
Next Earnings Date8/13/2020 (Estimated)8/3/2020 (Estimated)8/3/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.